Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
Obstructive lung diseases like COPD cause trouble when you're exhaling air. Restrictive lung diseases like pulmonary fibrosis make it harder to inhale air, reducing total lung capacity. There are two ...
WILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of ...
Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD ...
TARRYTOWN, N.Y. and PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use ...
Chronic obstructive pulmonary disease (COPD) is the world’s third leading cause of death. Although often overlooked, it is still widespread, currently affecting around 391 million individuals ...
Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results